{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:10:04Z","timestamp":1761491404784,"version":"3.41.2"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>A better understanding of the impact of early innate immune responses after vaccine priming on vaccine-elicited adaptive immune responses could inform rational design for effective HIV vaccines. The current study compared the whole blood molecular immune signatures of a 3M-052-SE adjuvanted HIV Env protein vaccine to a regimen combining the adjuvanted Env protein with simultaneous administration of a modified Vaccinia Ankara vector expressing HIV Env in infant rhesus macaques at days 0, 1, and 3 post vaccine prime. Both vaccines induced a rapid innate response, evident by elevated inflammatory plasma cytokines and altered gene expression. We identified 25 differentially-expressed genes (DEG) on day 1 compared to day 0 in the HIV protein vaccine group. In contrast, in the group that received both the Env protein and the MVA-Env vaccine only two DEG were identified, implying that the MVA-Env modified the innate response to the adjuvanted protein vaccine. By day 3, only three DEG maintained altered expression, indicative of the transient nature of the innate response. The DEG represented immune pathways associated with complement activation, type I interferon and interleukin signaling, pathogen sensing, and induction of adaptive immunity. DEG expression on day 1 was correlated to Env-specific antibody responses, in particular antibody-dependent cytotoxicity responses at week 34, and Env-specific follicular T helper cells. Results from network analysis supported the interaction of DEG and their proteins in B cell activation. These results emphasize that vaccine-induced HIV-specific antibody responses can be optimized through the modulation of the innate response to the vaccine prime.<\/jats:p>","DOI":"10.3389\/fimmu.2022.840976","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T13:14:54Z","timestamp":1651065294000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques"],"prefix":"10.3389","volume":"13","author":[{"given":"K. K. Vidya","family":"Vijayan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn A.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Alan D.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen K. A.","family":"Van Rompay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Pollara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Hudgens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"De Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"B1","unstructured":"2021- Global Aids Update2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400476111","article-title":"Systems Vaccinology: Probing Humanity's Diverse Immune Systems With Vaccines","volume":"111","author":"Pulendran","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.072","article-title":"Systems Vaccinology: Enabling Rational Vaccine Design With Systems Biological Approaches","volume":"33","author":"Hagan","year":"2015","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/nyas.14235","article-title":"Vaccine Innovations for Emerging Infectious Diseases-a Symposium Report","volume":"1462","author":"Cable","year":"2020","journal-title":"Ann NY Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25797","article-title":"Structure-Guided Envelope Trimer Design in HIV-1 Vaccine Development: A Narrative Review","author":"Derking","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.12.008","article-title":"Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines","volume":"38","author":"Obermoser","year":"2013","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging Concepts in the Science of Vaccine Adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1621489114","article-title":"Systems Analysis of Protective Immune Responses to RTS,s Malaria Vaccination in Humans","volume":"114","author":"Kazmin","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.05.003","article-title":"Systems Biological Approaches to Measure and Understand Vaccine Immunity in Humans","volume":"25","author":"Li","year":"2013","journal-title":"Semin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular Signatures of Antibody Responses Derived From a Systems Biology Study of Five Human Vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/COH.0b013e32834dc37b","article-title":"Systems Vaccinology: Its Promise and Challenge for HIV Vaccine Development","volume":"7","author":"Nakaya","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2067","article-title":"Systems Biology of Vaccination for Seasonal Influenza in Humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1688","article-title":"Systems Biology Approach Predicts Immunogenicity of the Yellow Fever Vaccine in Humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009363","article-title":"Innate Immune Signatures to a Partially-Efficacious HIV Vaccine Predict Correlates of HIV-1 Infection Risk","volume":"17","author":"Andersen-Nissen","year":"2021","journal-title":"PloS Pathog"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00162-20","article-title":"HIV Env-Specific Igg Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and can be Augmented by a Late Booster Immunization in Infancy","volume":"5","author":"Curtis","year":"2020","journal-title":"mSphere"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01783-18","article-title":"Co-Administration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques","volume":"93","author":"Dennis","year":"2019","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.3","article-title":"Novel Conserved-Region T-Cell Mosaic Vaccine With High Global HIV-1 Coverage is Recognized by Protective Responses in Untreated Infection","volume":"24","author":"Ondondo","year":"2016","journal-title":"Mol Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate Normalization of Real-Time Quantitative RT-PCR Data by Geometric Averaging of Multiple Internal Control Genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz369","article-title":"G:Profiler: A Web Server for Functional Enrichment Analysis and Conversions of Gene Lists (2019 Update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1131","article-title":"STRING V11: Protein-Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2829","article-title":"Targeting Innate Immunity Protein Kinase Signalling in Inflammation","volume":"8","author":"Gaestel","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05122.x","article-title":"Signaling of C-Kit in Dendritic Cells Influences Adaptive Immunity","volume":"1183","author":"Ray","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3561","article-title":"Dances With Cytokines, Featuring TFH Cells, IL-21, IL-4 and B Cells","volume":"17","author":"Belanger","year":"2016","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nri3803","article-title":"A Brief History of T Cell Help to B Cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600318","article-title":"A Cytokine-Independent Approach to Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood","volume":"197","author":"Dan","year":"2016","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4049\/jimmunol.1600320","article-title":"Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique","volume":"197","author":"Havenar-Daughton","year":"2016","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/icb.2009.64","article-title":"Early Commitment of Naive Human CD4(+) T Cells to the T Follicular Helper (T(FH)) Cell Lineage is Induced by IL-12","volume":"87","author":"Ma","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02218-4","article-title":"CXCR5(+) T Cells: Follicular Homing Takes Center Stage in T-Helper-Cell Responses","volume":"23","author":"Moser","year":"2002","journal-title":"Trends Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nri1714","article-title":"Follicular B Helper T Cells in Antibody Responses and Autoimmunity","volume":"5","author":"Vinuesa","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7388.1","article-title":"Can Follicular Helper T Cells be Targeted to Improve Vaccine Efficacy","volume":"5","author":"Linterman","year":"2016","journal-title":"F1000Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1208972109","article-title":"Merck Ad5\/HIV Induces Broad Innate Immune Activation That Predicts CD8(+) T-Cell Responses But is Attenuated by Preexisting Ad5 Immunity","volume":"109","author":"Zak","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw4236","article-title":"A Vaccine-Induced Gene Expression Signature Correlates With Protection Against SIV and HIV in Multiple Trials","volume":"11","author":"Ehrenberg","year":"2019","journal-title":"Sci Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: From 1920 to 2015 and Beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017011411","article-title":"Innate Transcriptional Effects by Adjuvants on the Magnitude, Quality, and Durability of HIV Envelope Responses in Nhps","volume":"1","author":"Francica","year":"2017","journal-title":"Blood Adv"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01051-18","article-title":"Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques","volume":"92","author":"Phillips","year":"2018","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-388579","article-title":"Distinct TLR Adjuvants Differentially Stimulate Systemic and Local Innate Immune Responses in Nonhuman Primates","volume":"119","author":"Kwissa","year":"2012","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1700063","article-title":"Recent Advances in the Discovery and Delivery of TLR7\/8 Agonists as Vaccine Adjuvants","volume":"2","author":"Dowling","year":"2018","journal-title":"Immunohorizons"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1995.15.537","article-title":"Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and s-27609","volume":"15","author":"Gibson","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(95)00054-P","article-title":"Immunomodulating and Antiviral Activities of the Imidazoquinoline s-28463","volume":"28","author":"Tomai","year":"1995","journal-title":"Antiviral Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01936-06","article-title":"Adenovirus Infection Triggers a Rapid, Myd88-Regulated Transcriptome Response Critical to Acute-Phase and Adaptive Immune Responses in Vivo","volume":"81","author":"Hartman","year":"2007","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2007.016","article-title":"Role of Myd88 and TLR9 in the Innate Immune Response Elicited by Serotype 5 Adenoviral Vectors","volume":"18","author":"Yamaguchi","year":"2007","journal-title":"Hum Gene Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02685-06","article-title":"Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator","volume":"81","author":"Nociari","year":"2007","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02192-06","article-title":"Innate Immune Response to Adenoviral Vectors is Mediated by Both Toll-Like Receptor-Dependent and -Independent Pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.01.065","article-title":"Co-Administration of Viral Vector-Based Vaccines Suppresses Antigen-Specific Effector CD8 T Cells","volume":"28","author":"Yashima","year":"2010","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01617-08","article-title":"Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components","volume":"83","author":"Waibler","year":"2009","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development","volume":"97","author":"Volz","year":"2017","journal-title":"Adv Virus Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032220","article-title":"Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein","volume":"7","author":"Falivene","year":"2012","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01648-18","article-title":"Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-Apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses","volume":"93","author":"Chea","year":"2019","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome","volume":"5","author":"Delaloye","year":"2009","journal-title":"PloS Pathog"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01190-07","article-title":"Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses","volume":"81","author":"Waibler","year":"2007","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1038\/s41598-018-21222-2","article-title":"Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response","volume":"8","author":"Palgen","year":"2018","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2017.00225","article-title":"Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact Myd88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production","volume":"8","author":"Mosaheb","year":"2017","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.06.080","article-title":"Evaluation of Novel Synthetic TLR7\/8 Agonists as Vaccine Adjuvants","volume":"34","author":"Smith","year":"2016","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.811208","article-title":"The Use of Toll-Like Receptor 7\/8 Agonists as Vaccine Adjuvants","volume":"12","author":"Vasilakos","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2182","article-title":"TLR Signaling Fine-Tunes Anti-Influenza B Cell Responses Without Regulating Effector T Cell Responses","volume":"178","author":"Heer","year":"2007","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nri3190","article-title":"Integration of B Cell Responses Through Toll-Like Receptors and Antigen Receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-immunol-030409-101216","article-title":"Early Events in B Cell Activation","volume":"28","author":"Harwood","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200635993","article-title":"Early Type I Interferon-Mediated Signals on B Cells Specifically Enhance Antiviral Humoral Responses","volume":"36","author":"Fink","year":"2006","journal-title":"Eur J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-Alpha\/Beta Enhances BCR-Dependent B Cell Responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The Induction of Antibody Production by IL-6 is Indirectly Mediated by IL-21 Produced by CD4+ T Cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2012.17","article-title":"IL-6 Triggers IL-21 Production by Human CD4+ T Cells to Drive STAT3-Dependent Plasma Cell Differentiation in B Cells","volume":"90","author":"Diehl","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200601","article-title":"Potent Induction of Antibody-Secreting B Cells by Human Dermal-Derived CD14+ Dendritic Cells Triggered by Dual TLR Ligation","volume":"189","author":"Matthews","year":"2012","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.840976\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T13:15:09Z","timestamp":1651065309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.840976\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2022.840976"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.840976","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"article-number":"840976"}}